Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Zofran (ondansetron) is a prescription anti-nausea medication that blocks serotonin signals in the gut and brain, and it is most often used to prevent nausea and vomiting caused by chemotherapy, radiation, surgery and anesthesia, with off-label use for severe gastroenteritis, migraine-related vomiting and pregnancy sickness. Onset depends on the form: IV doses typically work within 10 to 30 minutes, while oral tablets, orally disintegrating tablets and liquid usually bring relief in about 30 minutes to 2 hours, with effects lasting roughly 4 to 8 hours. Dosing, timing before treatment, drug interactions, heart rhythm risks and age-specific cautions vary considerably, so there are several important factors to consider before use. See below for the complete answer, including side effects, warnings and situations where Zofran is not the right choice.
Because persistent nausea and vomiting can signal anything from a passing stomach bug to dehydration, pregnancy, migraine or a more serious condition that medication alone will not fix, it is worth spending three minutes on a free, instant, online symptom check to clarify what may be driving your symptoms and what step to take next.
Last reviewed for medical accuracy: 10/01/2025
Zofran (generic name: ondansetron), often referred to by the brand name zophran, is a widely prescribed medication designed to prevent and treat nausea and vomiting. Below, you’ll find clear, concise information about its uses, onset of action, forms, dosing, side effects, and precautions—so you can feel informed and confident when discussing this treatment with your healthcare provider.
Zophran is a 5-HT₃ (serotonin) receptor antagonist. By blocking serotonin signals in the gut and brain, it reduces the sensation of nausea and the urge to vomit. Common approved uses include:
Off-label uses (supported by clinical experience) may include:
Onset and peak effects vary by formulation:
| Formulation | Onset of Action | Time to Peak Concentration |
|---|---|---|
| Oral tablet | 30 minutes | 1–2 hours |
| Orally disintegrating tablet | 15–30 minutes | 1–1.5 hours |
| Oral solution | 15–30 minutes | 1–1.5 hours |
| Intravenous (IV) injection | 5 minutes | 15–30 minutes |
Always follow your doctor’s instructions. Typical adult dosing:
Pediatric and pregnancy dosing requires specialized guidance. Never adjust your dose without consulting a healthcare professional.
Most people tolerate zophran well. Common, generally mild side effects include:
These effects often improve as your body adjusts. Stay hydrated and rest if you feel lightheaded.
Though rare, certain side effects require immediate medical attention:
Precautions:
Zophran can significantly reduce nausea, but persistent or severe vomiting can lead to dehydration, malnutrition, or other complications. If you experience:
…you should speak to a doctor right away.
For non-urgent guidance about your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help determine your next steps. Its interactive questions can point you toward the most appropriate care—whether that’s self-care at home or seeking immediate medical attention.
Zophran (zophran) is a proven, generally well-tolerated option for managing nausea and vomiting associated with chemotherapy, surgery, radiation, and other causes. It works quickly—sometimes within minutes (IV) or within half an hour (oral)—and comes in multiple forms to suit your situation.
This information is intended to help you understand how zophran works and what to expect, but it’s not a substitute for professional medical advice. If you have serious or life-threatening concerns, speak to your doctor immediately. Always follow your healthcare provider’s instructions and report any unusual or severe side effects without delay.
(References)
* Priestley GS, Seavell CR. Ondansetron for the prevention of nausea and vomiting. Anaesth Intensive Care. 1995 Feb;23(1):122. PMID: 7778732.
* Forster ER, Palmer JL. Comment: Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmacother. 1994 Oct;28(10):1203-4. doi: 10.1177/106002809402801022. PMID: 7841589.
* Lewis MA, Fishman DA. Ondansetron for postoperative nausea and vomiting: decisions in the absence of comparative trials. Am J Hosp Pharm. 1994 Feb 15;51(4):524-5. PMID: 8017423.
* Hindle AT. Ondansetron and the prevention of postoperative nausea and vomiting. Anaesthesia. 1993 Oct;48(10):919-21. doi: 10.1111/j.1365-2044.1993.tb07441.x. PMID: 8238846.
* Gridelli C, Incoronato P, Airoma G, Pepe R, Arpinelli F, Bianco AR. Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy. Eur J Cancer. 1993;29A(4):651. doi: 10.1016/s0959-8049(05)80191-1. PMID: 8435225.
* Marsden SC. Use of ondansetron (Zofran). N Z Med J. 1993 Apr 28;106(954):166. PMID: 8479670.
* Perevodchikova NI, Volkova MA, Gorbunova VA, Manziuk LV, Marenich AF, Smirnova NB. [The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients]. Ter Arkh. 1996;68(2):30-4. PMID: 8771653.
* Lawhorn S, Lawhorn CD, Davison C. Ondansetron eliminates nausea and vomiting associated with prostacyclin in a patient awaiting lung transplantation. J Heart Lung Transplant. 1997 Apr;16(4):472-3. PMID: 9154961.
* Phillips J. Ondansetron versus droperidol for postoperative nausea and vomiting. Anesth Analg. 1999 Feb;88(2):465-6. doi: 10.1097/00000539-199902000-00047. PMID: 9972777.
* Diemunsch P, Gan TJ, Philip BK, Girao MJ, Eberhart L, Irwin MG, Pueyo J, Chelly JE, Carides AD, Reiss T, Evans JK, Lawson FC, Aprepitant-PONV Protocol 091 International Study Group. Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth. 2007 Aug;99(2):202-11. doi: 10.1093/bja/aem133. Epub 2007 May 30. PMID: 17540667.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.